Brief: Acorda Therapeutics Says Issued 6.00% Convertible Senior Secured Notes Due 2024 An Aggregate Of 8.9 Mln Shares Of Common Stock
01/12/2020 22:52
Dec 1 (Reuters) - Acorda Therapeutics Inc ACOR.O :
* ACORDA THERAPEUTICS INC - ISSUED 6.00% CONVERTIBLE SENIOR
SECURED NOTES DUE 2024 AN AGGREGATE OF 8.9 MILLION SHARES OF
COMMON STOCK
* ACORDA THERAPEUTICS - PURSUANT TO ISSUANCE, AMOUNT
CORRESPONDING
TO $6.2 MILLION OF ACCRUED INTEREST WILL BE RELEASED FROM ESCROW
Source: (https://bit.ly/3of11DM)
Further company coverage: ACOR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acorda Therapeutics
See all newsBrief: Acorda TherapeuticsCourt Held Hearing To Consider Approval Of Sale Of Substantially All Of Co's Assets To Merz Pharmaceuticals Under Asset Sale
Brief: Acorda Says Debtors Did Not Receive More Than One Qualified Bid Before Bid Deadline, In Connection With Chapter 11 Proceedings
Live Markets: Biotech companies in 'Darwinian' world as cash remains king
U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease (updated)
U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease